Industrial Research Project to develop implanted electrodes to treat brain tumours

多形性胶质母细胞瘤（GBM）是最具侵袭性的脑癌。即使采用最好的治疗方法，患者在确诊后也只能存活14个月。GBM很难治疗，5年生存率为5%；相比之下，乳腺癌的这一比例为89%。GBM患者迫切需要更有效的治疗方法，在QV Bioelectronics，我们的目标是开发一种电疗设备，提供无痛，无副作用的治疗，以改善GBM患者的临床结果。这个创新英国资助的项目旨在进行工业研究，以支持我们医疗设备的发展。该项目的成果将用于为我们技术的最终临床应用奠定基础，为全世界的脑肿瘤患者带来益处。

Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer. Even with the best available treatment, patients are only expected to live 14 months post-diagnosis. GBM is very difficult to treat, with the 5-year survival rate at 5%; by comparison, this figure is 89% for breast cancer. GBM patients are in desperate need for more effective treatments, and at QV Bioelectronics our goal is to develop an electrotherapy device to provide pain-free, side-effect free treatment to improve the clinical outcomes for GBM patients.This Innovate UK funded project aims to conduct industrial research to support the development our medical device. The outputs of this project will be used to lay the foundations of the eventual clinical translation of our technology, bringing benefits to brain tumour patients worldwide.